Alpha IVD participated in AMCLI 2025, Italy’s leading clinical microbiology congress, held at the Congress Palacongressi di Rimini from March 25-28, 2025. This prestigious event gathered distinguished experts, researchers, and healthcare professionals to exchange knowledge and explore the latest advancements in infectious disease diagnostics.
A key highlight of our participation was the workshop we contributed, titled “The Evolution of Molecular Diagnostics of Sepsis: New Frontiers of Diagnostic Tools”. We extend our sincere gratitude to all attendees for their engagement and valuable discussions during this insightful session.
We are especially grateful to our esteemed speakers, Francesco Cristini, Dr. Massimo Girardis, and Dr. Chiara Vismara, for sharing their expertise and pioneering insights into the molecular diagnosis of sepsis. Additionally, we appreciate the invaluable contributions of our moderators, Prof. Pierangelo Clerici and Prof. Nicasio Mancini, whose leadership facilitated an engaging and thought-provoking discussion.
Throughout the congress, at Booth 9, attendees had the opportunity to explore Alpha IVD’s and Anatolia Geneworks’ latest molecular diagnostic solutions, particularly in the field of infectious disease detection and sepsis diagnostics.
We sincerely thank all who visited our booth, attended our workshop, and engaged in meaningful discussions.
